Evidence map›Paper›PMID 32020870›Full record

ArticleBMC complementary medicine and therapies2020

Alisol A-24-acetate promotes glucose uptake via activation of AMPK in C2C12 myotubes.

Jia-Xiang Chen, Hai-Yan Li, Tian-Tian Li, Wen-Cheng Fu, Xin Du, Chun-Hui Liu, Wen Zhang

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Alisols A-C and their acetate derivatives: a review of natural occurrence, pharmacology, semisynthesis, pharmacokinetics, and metabolism.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Terpenoid natural products exert neuroprotectionFrontiers in pharmacology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jia-Xiang ChenSchool of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China.
Hai-Yan LiSchool of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China.
Tian-Tian LiSchool of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China.
Wen-Cheng FuSchool of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China.
Xin DuSchool of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China.
Chun-Hui LiuChina national institute of standardization, 4 Zhichun Road, Beijing, 100191, China. liuchh@cnis.ac.cn.
Wen ZhangSchool of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China. wzhang@bio.ecnu.edu.cn.
East China Normal University · CNChina National Institute of Standardization · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlisol A-24-acetate (AA-24-a) is one of the main active triterpenes isolated from the well-known medicinal plant Alisma orientale (Sam.) Juz., which possesses multiple biological activities, including a hypoglycemic effect. Whether AA-24-a is a hypoglycemic-active compound of A. orientale (Sam.) Juz. is unclear. The present study aimed to clarify the effect and potential mechanism of action of AA-24-a on glucose uptake in C2C12 myotubes.

methodEffects of AA-24-a on glucose uptake and GLUT4 translocation to the plasma membrane were evaluated. Glucose uptake was determined using a 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino)-2-deoxyglucose (2-NBDG) uptake assay. Cell membrane proteins were isolated and glucose transporter 4 (GLUT4) protein was detected by western blotting to examine the translocation of GLUT4 to the plasma membrane. To determine the underlying mechanism, the phosphorylation levels of proteins involved in the insulin and 5'-adenosine monophosphate-activated protein kinase (AMPK) pathways were examined using western blotting. Furthermore, specific inhibitors of key enzymes in AMPK signaling pathway were used to examine the role of these kinases in the AA-24-a-induced glucose uptake and GLUT4 translocation.

resultsWe found that AA-24-a significantly promoted glucose uptake and GLUT4 translocation in C2C12 myotubes. AA-24-a increased the phosphorylation of AMPK, but had no effect on the insulin-dependent pathway involving insulin receptor substrate 1 (IRS1) and protein kinase B (PKB/AKT). In addition, the phosphorylation of p38 mitogen-activated protein kinase (MAPK) and the AKT substrate of 160 kDa (AS160), two proteins that act downstream of AMPK, was upregulated. Compound C, an AMPK inhibitor, blocked AA-24-a-induced AMPK pathway activation and reversed AA-24-a-induced glucose uptake and GLUT4 translocation to the plasma membrane, indicating that AA-24-a promotes glucose metabolism via the AMPK pathway in vitro. STO-609, a calcium/calmodulin-dependent protein kinase kinase β (CaMKKβ) inhibitor, also attenuated AA-24-a-induced glucose uptake and GLUT4 translocation. Moreover, STO-609 weakened AA-24-a-induced phosphorylation of AMPK, p38 MAPK and AS160.

conclusionsThese results indicate that AA-24-a isolated from A. orientale (Sam.) Juz. significantly enhances glucose uptake via the CaMKKβ-AMPK-p38 MAPK/AS160 pathway.

Indexed as

AlismaAMP-Activated Protein KinasesAnimalsBlotting, WesternCell LineCholestenonesGlucoseGlucose Transporter Type 4MiceMuscle Fibers, SkeletalPilot ProjectsPlants, Medicinalalisol A 24-acetateAMP-Activated Protein KinasesCholestenonesGlucoseGlucose Transporter Type 4Slc2a4 protein, mouseAlisol A-24-acetateAMPKC2C12 myotubesGlucose uptake

Identifiers

PMID32020870
PMCPMC7076831
OpenAlexW3013429553

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.